UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of a low-glycemic index or a high-cereal fiber diet on type 2 diabetes: a randomized trial

JAMA : the journal of the American Medical Association, 2008-12, Vol.300 (23), p.2742

2008

Volltextzugriff (PDF)

Development of food literacy in children and adolescents: implications for the design of strategies to promote healthier and more sustainable diets

Nutrition reviews, 2024-03, Vol.82 (4), p.536-552

2024

Volltextzugriff (PDF)

Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer

The New England journal of medicine, 2018-11, Vol.379 (21), p.2040-2051

2018

Volltextzugriff (PDF)

Young and Worried: Age and Fear of Recurrence in Breast Cancer Survivors

Health psychology, 2013-06, Vol.32 (6), p.695-705

2013

Volltextzugriff (PDF)

The impact of motherhood on perceived stress, illness intrusiveness and fear of cancer recurrence in young breast cancer survivors over time

Psychology & health, 2014-06, Vol.29 (6), p.651-670

2014

Volltextzugriff (PDF)

Special Treatment and Wound Care of the Driveline Exit Site after Left Ventricular Assist Device Implantation

The Thoracic and cardiovascular surgeon, 2015-12, Vol.63 (8), p.670-674

2015

Volltextzugriff (PDF)

The end of obesity

Canadian Family Physician, 1999, Vol.45, p.143

1999

Volltextzugriff (PDF)

Analysis of patients with relapsed small cell lung cancer (SCLC) receiving single-agent lurbinectedin in the phase 3 ATLANTIS trial

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.8524-8524

2022

Volltextzugriff (PDF)

Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial

The lancet respiratory medicine, 2023-01, Vol.11 (1), p.74-86

2023

Volltextzugriff (PDF)

Diffusion tensor imaging and white matter lesions at the subacute stage in mild traumatic brain injury with persistent neurobehavioral impairment

Human brain mapping, 2011-06, Vol.32 (6), p.999-1011

2011

Volltextzugriff (PDF)

Efficacy and safety of lurbinectedin in elderly patients with relapsed SCLC

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.8591-8591

2023

Volltextzugriff (PDF)

368 Consistent pattern of immune activation induced by oncolytic adenovirus ONCOS-102 across diverse types of solid tumors

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A396-A396

2021

Volltextzugriff (PDF)

462 A randomised open-label phase I/II study adding ONCOS-102 to pemetrexed/cisplatin in patients with unresectable malignant pleural mesothelioma – 24 month survival data

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A491-A491

2021

Volltextzugriff (PDF)

European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I

European urology, 2008-03, Vol.53 (3), p.478-496

2008

Volltextzugriff (PDF)

361 A randomised open-label phase I/II study adding ONCOS-102 to pemetrexed/cisplatin in patients with unresectable malignant pleural mesothelioma – 12 month analysis of biomarkers and clinical outcomes

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A220-A221

2020

Volltextzugriff (PDF)

European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II

European urology, 2008-03, Vol.53 (3), p.497-513

2008

Volltextzugriff (PDF)

Efficacy and safety profile of lurbinectedin in second-line SCLC patients: Results from a phase II single-agent trial

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.8506-8506

2019

Volltextzugriff (PDF)

Motherhood and well-being in young breast cancer survivors

Breast cancer management, 2018-02, Vol.7 (1)

2018

Volltextzugriff (PDF)

Rimado de palacio – Preuve/Épreuve (XIIIe-XVIe s.) – Pouvoirs de la noblesse

e-Spania, 2019-10

2019

Volltextzugriff (PDF)

new α-helical extension promotes RNA binding by the dsRBD of Rnt1p RNAse III

The EMBO journal, 2004-07, Vol.23 (13), p.2468-2477

2004

Volltextzugriff (PDF)

GAIN-(L): Efficacy and biomarker findings of RG7160 (GA201), a novel, dual-acting monoclonal antibody (mAb) designed to enhance antibody-dependent cellular cytotoxicity (ADCC), in combination with first-line cisplatin and pemetrexed in metastatic nonsquamous NSCLC

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.7544-7544

2012

Volltextzugriff (PDF)

Abstract LB-220: Translational research with RG7160 (GA201) leads to a phase II clinical study in combination with FOLFIRI in 2nd line metastatic colorectal cancer (mCRC)

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.LB-220-LB-220

2012

Volltextzugriff (PDF)

Corrigendum to: “European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I” [Eur Urol 2008;53:478–96] and to: “European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part II” [Eur Urol 2008;53:497–513]

European urology, 2008-08, Vol.54 (2), p.480-480

2008

Volltextzugriff (PDF)

A new [alpha]-helical extension promotes RNA binding by the dsRBD of Rnt1p RNAse III

The EMBO journal, 2004-07, Vol.23 (13), p.2468-2477

2004

Volltextzugriff (PDF)

Matières

Agôn, 2019-12

2019

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(24)
Reviews
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effect of a low-glycemic index or a high-cereal fiber diet on type 2 diabetes: a randomized trial

Development of food literacy in children and adolescents: implications for the design of strategies to promote healthier and more sustainable diets

Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer

Young and Worried: Age and Fear of Recurrence in Breast Cancer Survivors

The impact of motherhood on perceived stress, illness intrusiveness and fear of cancer recurrence in young breast cancer survivors over time

Special Treatment and Wound Care of the Driveline Exit Site after Left Ventricular Assist Device Implantation

The end of obesity

Analysis of patients with relapsed small cell lung cancer (SCLC) receiving single-agent lurbinectedin in the phase 3 ATLANTIS trial

Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial

Diffusion tensor imaging and white matter lesions at the subacute stage in mild traumatic brain injury with persistent neurobehavioral impairment

Efficacy and safety of lurbinectedin in elderly patients with relapsed SCLC

368 Consistent pattern of immune activation induced by oncolytic adenovirus ONCOS-102 across diverse types of solid tumors

462 A randomised open-label phase I/II study adding ONCOS-102 to pemetrexed/cisplatin in patients with unresectable malignant pleural mesothelioma – 24 month survival data

European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I

361 A randomised open-label phase I/II study adding ONCOS-102 to pemetrexed/cisplatin in patients with unresectable malignant pleural mesothelioma – 12 month analysis of biomarkers and clinical outcomes

European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II

Efficacy and safety profile of lurbinectedin in second-line SCLC patients: Results from a phase II single-agent trial

Motherhood and well-being in young breast cancer survivors

Rimado de palacio – Preuve/Épreuve (XIIIe-XVIe s.) – Pouvoirs de la noblesse

new α-helical extension promotes RNA binding by the dsRBD of Rnt1p RNAse III

GAIN-(L): Efficacy and biomarker findings of RG7160 (GA201), a novel, dual-acting monoclonal antibody (mAb) designed to enhance antibody-dependent cellular cytotoxicity (ADCC), in combination with first-line cisplatin and pemetrexed in metastatic nonsquamous NSCLC

Abstract LB-220: Translational research with RG7160 (GA201) leads to a phase II clinical study in combination with FOLFIRI in 2nd line metastatic colorectal cancer (mCRC)

A new [alpha]-helical extension promotes RNA binding by the dsRBD of Rnt1p RNAse III

Matières

Suchergebnisse filtern